Abstract
Snake venoms have evolved over millions of years, and some toxins have evolved to specifically target various sites in the cardiovascular system of prey animals, producing prey hypotension. So far, a number of specific hypotensive peptides have been identified from different snake venoms. These snake hypotensive peptides are divided into five classes: bradykinin potentiating peptides, natriuretic peptides, sarafotoxins, Phospholipases A2 and L-type Ca2+ channel blockers. They differ widely in their structure, mechanism and points of action. Each class has many different isoforms with similar structures but different hypotensive activities. In the last decade, research efforts on snake hypotensive peptides have produced great advance in their understanding and applications in designing antihypertensive agents. In addition, several new classes of hypotensive peptides have been found from snake venoms. This review attempts to provide an overview of the current understanding of the structure, function and mechanism of snake hypotensive peptides.
Keywords: Bradykinin potentiating peptide, Cardiovascular effect, Hypotensive peptide, L-type calcium channel, Natriuretic peptide, Phospholipase A2, Sarafatoxin, Snake venom.
Current Topics in Medicinal Chemistry
Title:Hypotensive Peptides from Snake Venoms: Structure, Function and Mechanism
Volume: 15 Issue: 7
Author(s): Xiaolong Xu, Bing Li, Shanshan Zhu and Rui Rong
Affiliation:
Keywords: Bradykinin potentiating peptide, Cardiovascular effect, Hypotensive peptide, L-type calcium channel, Natriuretic peptide, Phospholipase A2, Sarafatoxin, Snake venom.
Abstract: Snake venoms have evolved over millions of years, and some toxins have evolved to specifically target various sites in the cardiovascular system of prey animals, producing prey hypotension. So far, a number of specific hypotensive peptides have been identified from different snake venoms. These snake hypotensive peptides are divided into five classes: bradykinin potentiating peptides, natriuretic peptides, sarafotoxins, Phospholipases A2 and L-type Ca2+ channel blockers. They differ widely in their structure, mechanism and points of action. Each class has many different isoforms with similar structures but different hypotensive activities. In the last decade, research efforts on snake hypotensive peptides have produced great advance in their understanding and applications in designing antihypertensive agents. In addition, several new classes of hypotensive peptides have been found from snake venoms. This review attempts to provide an overview of the current understanding of the structure, function and mechanism of snake hypotensive peptides.
Export Options
About this article
Cite this article as:
Xu Xiaolong, Li Bing, Zhu Shanshan and Rong Rui, Hypotensive Peptides from Snake Venoms: Structure, Function and Mechanism, Current Topics in Medicinal Chemistry 2015; 15 (7) . https://dx.doi.org/10.2174/1568026615666150217113835
DOI https://dx.doi.org/10.2174/1568026615666150217113835 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
Current Cardiology Reviews Opioids and Cannabinoids Interactions: Involvement in Pain Management
Current Drug Targets Enkephalinase Inhibitors: Potential Agents for the Management of Pain
Current Drug Targets Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
Current Cancer Drug Targets Hydrogen Sulfide-Based Therapies: Focus on H2S Releasing NSAIDs
Inflammation & Allergy - Drug Targets (Discontinued) Canagliflozin : A New Hope in the Antidiabetic Armamentarium
Recent Patents on Cardiovascular Drug Discovery Comparing the Molecular Pharmacology of CGRP and Adrenomedullin
Current Protein & Peptide Science Molecular Basis of Adrenomedullin 1 Receptor Function and Its Roles in the Cardiovascular System
Current Hypertension Reviews Synthesis, Physico-Chemical Properties and DFT Calculations of New 2-(4- Arylpiperazine-1-yl)-1-(3-ethylbenzofuran-2-yl)ethanols As Potential Antihypertensive Agents
Current Organic Chemistry Hypersensitivity Reactions to Last Generation Chimeric, Umanized and Human Recombinant Monoclonal Antibodies for Therapeutic Use
Current Pharmaceutical Design Design, Synthesis and Biological Evaluation of Benzopyran Derivatives as KATP Channel Openers
Letters in Drug Design & Discovery Novel Agents Aiming at Specific Molecular Targets Increase Chemosensitivity and Overcome Chemoresistance in Hematopoietic Malignancies
Current Pharmaceutical Design Entry of Oximes into the Brain: A Review
Current Medicinal Chemistry Cardiac Biomarkers in Acute Coronary Syndromes: A Review
Current Vascular Pharmacology Recent Developments in Pharmacologic Prophylaxis of Atrial Fibrillation in Patients Undergoing Surgical Revascularization
Cardiovascular & Hematological Agents in Medicinal Chemistry Gastroduodenal Safety of Cyclooxygenase-2 Inhibitors
Current Pharmaceutical Design Antioxidant Properties and Medicinal Uses of Some Crataegus Spp. (Hawthorn) Including <i>C. meyeri</i> and <i>C. pontica</i>
Current Nutrition & Food Science Ribonucleases, Nucleases and Antiangiogenins in Antiproliferative Activities
Current Signal Transduction Therapy Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Current Drug Targets Compendious Review on Bioactive Constituents and Pharmacotherapeutic Profile of Heliotropium indicum Linn
The Natural Products Journal